EP3086793
NOTKUN ILDAÐRA KÓLESTERÓLSÚLFATA (OCS) Í MEÐFERÐ VIÐ NÝRNAVANVIRKNI
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
23.12.2014EP published:
11.5.2022EP application number:
14874617.5
EP translation filed:
5.7.2022Grant published:
15.9.2022EPO information:
European Patent Register
Max expiry date:
22.12.2034Expiry date:
22.12.2024
Title in English:
USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) FOR THE TREATMENT OF KIDNEY DYSFUNCTIONLanguage of the patent:
English
Timeline
Today
23.12.2014EP application
11.5.2022EP Publication
5.7.2022Translation submitted
15.9.2022Registration published
22.12.2024Expires
Owner
Name:
Virginia Commonwealth UniversityAddress:
800 East Leigh Street Suite 3000, Richmond, VA 23298, US
Name:
The United States Government as Represented by the Department of Veterans AffairsAddress:
810 Vermont Avenue, N.W., Washington, DC 20420, US
Name:
Durect CorporationAddress:
10260 Bubb Road, Cupertino, CA 95014, US
Inventor
Name:
REN, ShunlinAddress:
Richmond, VA 23249, US
Name:
THEEUWES, FelixAddress:
Los Altos Hills, CA 94022, US
Name:
BROWN, James E.Address:
Los Gatos, CA 95032, US
Name:
LIN, WeiQiAddress:
Emerald Hills, VA 94062, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201361920617 PDate:
24.12.2013Country:
US
Classification
Categories:
A61K 31/575, A61K 31/56, A61P 43/00, A61P 1/16, A61K 31/568, A61K 35/12, A61P 13/12
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 15.1.2023
Expires: 22.12.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 15.12.2023
Expires: 22.12.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 15.12.2023
Expires: 22.12.2024
Payer: Árnason Faktor ehf.